Gold prices steady, holding sharp gains in wake of soft U.S. jobs data
On Thursday, Jefferies analyst James Vane-Tempest adjusted the price target for Gerresheimer AG (BS:GXId) (GXI:GR) (OTC:GRRMF) shares, bringing it down to €86.00 from the previous €93.00. Despite this reduction, the firm maintained a Buy rating on the stock. The revision follows the company’s first-quarter results, leading to a decrease in revenue estimates by 4-5% and EBITDA projections by 1-3%. The changes also take into account the company’s full-year guidance.
During a fireside chat hosted on Wednesday, Gerresheimer’s CEO provided insights that reaffirmed long-term trends for the company. The expectation remains that the year’s performance will be more heavily weighted towards the second half. The CEO underscored that a significant portion of the company’s growth is secured by existing contracts.
Jefferies continues to apply a sum-of-the-parts (SOTP) valuation approach to Gerresheimer. Although the price target has been slightly lowered, the analysis suggests that the current share price offers an undervalued perspective on the company’s Moulded Glass division. According to Vane-Tempest, the market is effectively assigning no value to this segment, which he implied could represent an unrecognized opportunity within the stock’s current pricing.
The financial firm’s outlook reflects an expectation of continued value in Gerresheimer’s business, despite the near-term adjustments to revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA). Gerresheimer AG specializes in the pharmaceutical and healthcare industry, providing packaging solutions and drug delivery systems, which are critical components of the healthcare supply chain.
Investors will likely watch Gerresheimer’s performance in the coming months, particularly in the second half of the year, to see if the company can deliver on its anticipated growth and justify the maintained Buy rating amidst the revised price target.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.